Giuseppe Ciaramella

2021

In 2021, Giuseppe Ciaramella earned a total compensation of $5.5M as President and CSO at Beam Therapeutics, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$380,250
Option Awards$2,643,830
Salary$500,000
Stock Awards$2,001,000
Other$10,542
Total$5,535,622

Ciaramella received $2.6M in option awards, accounting for 48% of the total pay in 2021.

Ciaramella also received $380.3K in non-equity incentive plan, $500K in salary, $2M in stock awards and $10.5K in other compensation.

Rankings

In 2021, Giuseppe Ciaramella's compensation ranked 2,311th out of 12,415 executives tracked by ExecPay. In other words, Ciaramella earned more than 81.4% of executives.

ClassificationRankingPercentile
All
2,311
out of 12,415
81st
Division
Manufacturing
902
out of 5,505
84th
Major group
Chemicals And Allied Products
346
out of 2,375
85th
Industry group
Drugs
300
out of 2,096
86th
Industry
Biological Products, Except Diagnostic Substances
94
out of 449
79th
Source: SEC filing on April 22, 2022.

Ciaramella's colleagues

We found two more compensation records of executives who worked with Giuseppe Ciaramella at Beam Therapeutics in 2021.

2021

John Evans

Beam Therapeutics

Chief Executive Officer

2021

Terry-Ann Burrell

Beam Therapeutics

Chief Financial Officer

News

You may also like